β-Cell Death and Mass in Syngeneically Transplanted Islets Exposed to Short- and Long-Term Hyperglycemia
Open Access
- 1 January 2002
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (1), 66-72
- https://doi.org/10.2337/diabetes.51.1.66
Abstract
We studied the effects of hyperglycemia on β-cell death and mass in syngeneically transplanted islets. Six groups of STZ-induced diabetic C57BL/6 mice were transplanted with 100 syngeneic islets, an insufficient β-cell mass to restore normoglycemia. Groups 1, 2, and 3 remained hyperglycemic throughout the study. Groups 4, 5, and 6 were treated with insulin from day 7 before transplantation to day 10 after transplantation. After insulin discontinuation, group 6 mice achieved definitive normoglycemia. Grafts were harvested at 3 (groups 1 and 4), 10 (groups 2 and 5), and 30 (groups 3 and 6) days after transplantation. On day 3, the initially transplanted β-cell mass (0.13 ± 0.01 mg) was dramatically and similarly reduced in the hyperglycemic and insulin-treated groups (group 1: 0.048 ± 0.002 mg; group 4: 0.046 ± 0.007 mg; P < 0.001). Extensive islet necrosis (group 1: 30.7%; group 4: 26.8%) and increased β-cell apoptosis (group 1: 0.30 ± 0.05%; group 4: 0.42 ± 0.07%) were found. On day 10, apoptosis remained increased in both hyperglycemic and insulin-treated mice (group 2: 0.44 ± 0.09%; group 5: 0.48 ± 0.08%) compared with normal pancreas (0.04 ± 0.03%; P < 0.001). In contrast, on day 30, β-cell apoptosis was increased in grafts exposed to sustained hyperglycemia (group 3: 0.37 ± 0.03%) but not in normoglycemic mice (group 6: 0.12 ± 0.02%); β-cell mass was selectively reduced in islets exposed to hyperglycemia (group 3: 0.046 ± 0.02 mg; group 6: 0.102 ± 0.009 mg; P < 0.01). In summary, even in optimal conditions, ∼60% of transplanted islet tissue was lost 3 days after syngeneic transplantation, and both apoptosis and necrosis contributed to β-cell death. Increased apoptosis and reduced β-cell mass were also found in islets exposed to chronic hyperglycemia, suggesting that sustained hyperglycemia increased apoptosis in transplanted β-cells.Keywords
This publication has 45 references indexed in Scilit:
- Mechanisms of Defective Glucose-Induced Insulin Release in Human Pancreatic Islets Transplanted to Diabetic Nude MiceJournal of Clinical Endocrinology & Metabolism, 1997
- Long Term Effects of Aminoguanidine on Insulin Release and Biosynthesis: Evidence That the Formation of Advanced Glycosylation End Products Inhibits B Cell FunctionEndocrinology, 1997
- Protection of mouse islet isografts from nonspecific inflammatory damage by recipient treatment with nicotinamide and 15-deoxyspergualinCell Transplantation, 1996
- Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis.JCI Insight, 1995
- THE AMELIORATION OF HYPERGLYCEMIA IN STREPTOZOTOCIN-INDUCED DIABETIC RATS AFTER THE INTRAPORTAL TRANSPLANTATION OF AN INSUFFICIENT NUMBER OF ISLETS BY NICOTINAMIDE TREATMENTTransplantation, 1995
- Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice.JCI Insight, 1995
- Transplanted beta cell response to increased metabolic demand. Changes in beta cell replication and mass.JCI Insight, 1994
- Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice.JCI Insight, 1993
- Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.JCI Insight, 1990
- Islet mass and function in diabetes and transplantationDiabetes, 1990